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Abstract We have investigated the binding and cleavage of
DNA by human topoisomerase I using a 160 bp restriction
fragment containing either natural bases or 5-methylcytosine
residues in place of cytosines. Experiments were performed in the
presence and absence of the antitumour drug camptothecin which
specifically inhibits topoisomerase I. Replacement of all cyto-
sines with 5-methylcytosine residues (i) reinforces the enzyme-
DNA interaction, (ii) enhances the stability of topoisomerase I-
DNA complexes and (iii) modulates the sequence selectivity of
camptothecin-induced DNA cleavage. The methyl group exposed
in the major groove of the double helix is identified as a critical
element for the interaction between topoisomerase I and DNA.
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1. Introduction
Topoisomerase I is an essential DNA-cleaving enzyme in-
volved in DNA replication, transcription, genetic recombina-
tion and other fundamental processes [1]. In addition, this
ubiquitous enzyme is a privileged target for antitumour and
antiviral drugs [2]. The reaction between double-stranded
DNA and topoisomerase I produces a covalent 3P-phospho-
rotyrosyl adduct, usually referred to as the cleavable complex.
Under physiological conditions, the DNA cleavage and liga-
tion reactions catalysed by the enzyme are tightly coordinated
and the covalent intermediate is barely detectable. The cleav-
age is coupled with the religation to restore continuity to the
DNA duplex. A number of drugs such as the antitumour
alkaloid camptothecin can convert topoisomerase I into a
cell poison by blocking the religation step, thereby enhancing
the formation of persistent DNA breaks responsible for cell
death [3].
The topoisomerase I-mediated cleavage of DNA is se-
quence-selective and occurs predominantly on the 3P side of
thymine residues. Camptothecin preferentially traps a subset
of the enzyme cutting sites, namely those containing a guanine
immediately 3P to the cleaved bond [4,5]. The drug binds at
the interface of the enzyme-DNA complex and interacts with
the G1 residue [6]. The methyl group of thymine which pro-
trudes into the major groove is therefore expected to play an
important role in the sequence-selective DNA recognition
process. Studies with synthetic oligonucleotides have shown
that both the removal of the CH3 group from T (by substitut-
ing uridine for thymidine) or its addition onto C (replacement
of cytosine with 5-methylcytosine) can a¡ect the cleavage ac-
tivity of the enzyme. The cutting reaction can be stimulated or
strongly inhibited depending on the position of the U or 5-
Me-C residues with respect to the cleavage site [7,8]. These
studies, and others performed with type I topoisomerase of
vaccinia virus [9], strongly suggest that interactions within the
major groove of DNA may be critical for the cleavage activity
of the enzyme.
To investigate further the mechanism of interaction between
topoisomerase I and the major groove of DNA, we have
compared the binding of the human enzyme to DNA contain-
ing either natural bases or 5-methylcytosine residues in place
of cytosines. The 160 bp DNA fragment used as a substrate
was elaborated by PCR using dATP, dTTP, dGTP and either
dCTP or 5-methyl-dCTP, chosen at will. The experiments
described in this paper show that the replacement of all cyto-
sines with 5-methylcytosine residues (i) reinforces the enzyme-
DNA interaction, (ii) enhances considerably the stability of
topoisomerase I-DNA complexes and (iii) modulates the se-
quence selectivity of camptothecin-induced DNA cleavage.
2. Materials and methods
2.1. Chemicals and enzymes
Camptothecin (Sigma Chemical Co., La VerpillieØre, France) was
dissolved in dimethyl sulphoxide at 1 mM and then further diluted
with water. [32P]Q-ATP was obtained from Amersham and 5-methyl-
dCTP was from Pharmacia. Restriction endonucleases EcoRI and
AvaI (Boehringer), Taq polymerase (Promega) and T4 polynucleotide
kinase (Pharmacia) were used according to the suppliers’ recom-
mended protocol in the activity bu¡er provided.
2.2. Polymerase chain reaction and labelling of DNA
The 160 base pair tyrT(A93) fragment used as a template was iso-
lated from the plasmid pKMp27 [10] by digestion with restriction
enzymes EcoRI and AvaI. The protocol used to incorporate 5-meth-
ylcytosine residues into DNA was identical to that previously used to
incorporate 7-deazapurine or 2,6-diaminopurine residues [11,12].
Brie£y, PCR reaction mixtures contained 10 ng of tyrT(A93) DNA
template, 1 WM each of the appropriate pair of primers (one with a 5P-
OH and one with a 5P-NH2 terminal group) required to allow 5P-
phosphorylation of the desired strand, 250 WM of each appropriate
dNTP or 5-methyl-dCTP instead of dCTP, and 5 units of Taq polym-
erase in a volume of 50 Wl containing 50 mM KCl, 10 mM Tris-HCl,
pH 8.3, 0.1% Triton X-100, and 1.5 mM MgCl2. To prevent un-
wanted primer-template annealing before the cycles began, the reac-
tions were heated to 60‡C before adding the Taq polymerase. After an
initial denaturing step of 3 min at 94‡C, 20 ampli¢cation cycles were
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performed, each cycle consisting of the following segments: 94‡C for
1 min, 37‡C for 2 min, and 72‡C for 10 min. After the last cycle, the
extension segment was continued for an additional 10 min at 72‡C,
followed by a 5 min segment at 55‡C and a 5 min segment at 37‡C.
Samples were then puri¢ed on a 6% non-denaturing polyacrylamide
gel. The puri¢ed PCR products were 5P-end labelled with [Q-32P]ATP
in the presence of T4 polynucleotide kinase and then the labelled
DNA was again puri¢ed by 6% polyacrylamide gel electrophoresis.
Finally, the labelled DNA was resuspended in 10 mM Tris-HCl, pH
7.0 bu¡er containing 10 mM NaCl.
2.3. Topoisomerase I binding to DNA
32P-Labelled tyrT DNA was incubated with 5 units of human top-
oisomerase I in the absence or presence of camptothecin for 45 min at
37‡C. Binding reactions were performed in the topoisomerase I bu¡er
containing 20 mM Tris-HCl pH 7.4, 60 mM KCl, 0.5 mM EDTA, 0.5
mM dithiothreitol, in a 20 Wl reaction volume. Samples were analysed
on a 6% non-denaturing polyacrylamide gel in TBE bu¡er (89 mM
Tris base, 89 mM boric acid, 2.5 mM Na2-EDTA, pH 8.3).
2.4. Sequencing of topoisomerase I-mediated DNA cleavage sites
Each reaction mixture contained 2 Wl of 32P 3P-end labelled DNA
(V1 WM), 5 Wl of water, 2 Wl of 10Utopoisomerase I bu¡er, and 10 Wl
of 20 WM camptothecin. After 10 min equilibration, the reaction was
initiated by addition of 2 Wl human topoisomerase I from TopoGen
Inc. (Columbus, OH). Samples were incubated for 45 min at 37‡C
prior to adding SDS to 0.25% and proteinase K to 250 Wg/ml in order
to dissociate the drug-DNA-topoisomerase I cleavable complexes. The
DNA was precipitated with ethanol and then resuspended in 5 Wl of
formamide-TBE loading bu¡er, denatured at 90‡C for 4 min and
chilled in ice for 4 min prior to loading on to the sequencing gel.
DNA cleavage products were resolved by electrophoresis under dena-
turing conditions in polyacrylamide gels (0.3 mm thick, 8% acryl-
amide containing 8 M urea). Electrophoresis was performed for about
2 h at 60 W in TBE bu¡er. Gels were soaked in 10% acetic acid for 15
min, transferred to Whatman 3MM paper, dried under vacuum at
80‡C, and analysed using a phosphorimager (Molecular Dynamics
445SI, ImageQuant version 4.1 software). Each resolved band on
the autoradiograph was assigned to a particular bond within the
DNA fragment by comparison of its position relative to guanine
markers generated by treatment of the DNA with dimethylsulphate
followed by piperidine-induced cleavage (G track).
3. Results and discussion
3.1. Topoisomerase I-DNA interaction
The binding of topoisomerase I to the tyrT DNA fragment
was studied by a conventional gel retardation assay. The 5P-
end 32P-labelled DNA fragment was incubated with human
topoisomerase I for 45 min at 37‡C prior to loading the sam-
ples on to a 6% non-denaturing polyacrylamide gel. The same
experiments were performed in the presence of 10 WM camp-
tothecin. The results in Fig. 1 show that the enzyme reacts
di¡erently with the DNA containing normal bases and its
analogue containing 5-methylcytosine residues. The addition
of the methyl group on cytosines facilitates considerably the
formation of topoisomerase I-DNA complexes. Two well re-
solved bands (arrows in Fig. 1) can be detected with the
modi¢ed DNA but not with the DNA containing canonical
bases. In fact, a retarded band can be seen with normal DNA,
just above the unbound DNA but this band is not well re-
solved compared to those detected with the modi¢ed DNA.
The addition of the methyl groups which project into the
major groove seems to promote the enzyme-DNA interaction.
It is interesting to note that the intensity of most retarded
bands is enhanced in the presence of camptothecin which
freezes covalent topoisomerase I-DNA complexes.
3.2. Stability of topoisomerase I-DNA complexes
Topoisomerase I binds to DNA and forms transient cova-
lent complexes via reaction of a tyrosine residue at the cata-
lytic site with the 3P phosphate of the cleaved strand of DNA.
When the complexes formed between normal DNA and top-
oisomerase I at 37‡C are shifted to 50‡C, the complexes dis-
sociate completely; no more retarded band is visible (Fig. 2).
In contrast, with the DNA containing 5-methylcytosine resi-
dues a large fraction of the complexes is still detectable after
incubating the samples for 30 min at 50‡C. The addition of
the methyl groups evidently increases the thermal stability of
the enzyme-DNA complexes.
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Fig. 1. Binding of topoisomerase I to DNA containing cytosine or
5-methylcytosine residues. Both normal and Me-C DNA were incu-
bated for 45 min at 37‡C with 4 units of human topoisomerase I in
the absence (lanes Topo I) or presence (lanes Cpt) of camptothecin
at 10 WM. 5 Wl of a solution containing 0.1% electrophoresis dyes
and 40% glycerol were added prior to loading the samples on a 6%
non-denaturing polyacrylamide gel.
Fig. 2. E¡ect of temperature on the stability of the DNA-topoiso-
merase I complexes. The DNA (normal or Me-C) was incubated
with 3 units topoisomerase I for 30 min at 37‡C and then for an-
other 30 min at 37‡C or 50‡C prior to gel electrophoresis. The lanes
marked DNA refer to the DNA control incubated at 37‡C and then
50‡C (30 min each) in the absence of the enzyme.
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The formation of topoisomerase I-DNA complexes is de-
pendent upon the ionic strength of the medium. Camptothe-
cin-stabilised cleavable complexes are rapidly reversible upon
increasing the salt concentration [13]. The native gel mobility
shift assay used in Figs. 1 and 2 was repeated in the presence
of varying NaCl concentrations and the unbound form of
DNA was quantitated by densitometry (it is more accurate
to quantitate the protein-free DNA band than the smeary
bands with normal DNA corresponding to the protein-DNA
complexes). As shown in Fig. 3, the amount of unbound
DNA was proportional to the amount of NaCl added. With
both DNA species, the complexes are sensitive to the salt
concentration but the e¡ect is much more pronounced with
normal DNA than with the methylated analogue. In the pres-
ence of 0.3 M NaCl, no more complexes are formed with
normal DNA whereas about 30% of the material remains
complexed with the DNA containing methylcytosine residues.
These results also suggest that the complexes between topo-
isomerase I and the methylated DNA are signi¢cantly more
stable than those formed with normal DNA.
3.3. Sequence selectivity of camptothecin-induced DNA
cleavage
To examine more closely the e¡ects of the incorporation of
methylated cytosines, topoisomerase cleavage sites induced by
camptothecin were mapped using the tyrT DNA. The 160 bp
PCR product was uniquely end-labelled at the 5P-end of the
upper strand and used as a substrate for the topoisomerase I
cleavage reaction in the absence and presence of 10 WM camp-
tothecin. The cleavage products were analysed on a sequenc-
ing polyacrylamide gel and the cleavage sites were then lo-
cated and analysed by densitometry. As shown in Fig. 4,
practically no bands can be detected in the absence of the
inhibitor. The cleavage sites are almost imperceptible under
the conditions used because the enzyme continually nicks and
closes the DNA. In sharp contrast, strong bands are produced
at several de¢ned positions in the presence of camptothecin
using both the methylated and non-methylated fragments.
However, the patterns of topoisomerase I cleavage di¡er
markedly for the two DNA species. Camptothecin strongly
promotes DNA cleavage by human topoisomerase I at di¡er-
ent nucleotide positions on normal and modi¢ed DNA. In
other words, the addition of the methyl group provokes a
major redistribution of the camptothecin-stabilised cleavage
sites. A few sites such as positions 26 and 33 (5P-ATsGA
and 5P-ATsTA) were detected with both the normal and
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Fig. 4. Sequence analysis of the cleavage sites stimulated by camptothecin. The tyrT fragment containing cytosine (normal DNA) or methylcy-
tosine residues (Me-C DNA) was incubated in the absence (3) or presence (+) of 10 WM camptothecin for 10 min prior to adding 2 Wl human
topoisomerase I (4 units). Reactions were allowed to proceed for 45 min at 37‡C then stopped with SDS-proteinase K treatment. Topoisomer-
ase I cleavage sites were analyzed on an 8% denaturing polyacrylamide gel. Numbers at the bottom of the gel show the nucleotide position, de-
termined with reference to the guanine nucleotide track (G). The position of the camptothecin-stimulated cleavage sites is indicated. Symbols
3, +, ++, and +++ correspond to no cleavage, weak, medium and strong cleavage, respectively. The sequence shown corresponds to that of
the DNA containing natural bases. In the modi¢ed DNA, cytosines are replaced with 5-methylcytosine residues.
Fig. 3. E¡ect of NaCl on the stability of the DNA-topoisomerase I
complexes. The DNA was incubated with 10 units topoisomerase I
for 30 min at 37‡C and then NaCl (0.05^0.5 M ¢nal concentration)
was added to the samples. After 15 min incubation at 37‡C, 5 Wl of
the loading solution was added and the products were electropho-
resed on a 6% polyacrylamide gel. The intensity of the band corre-
sponding to the unbound DNA was quantitated by densitometry.
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modi¢ed DNA. But in most cases, the cleavage sites are di¡er-
ent. Sites at positions 52 and 67 (5P-TTsCT and 5P-CTsTT)
are trapped by camptothecin with normal DNA but not with
the methylated DNA. Conversely, sites 46, 58 and 70 (5P-
TCsAT, 5P-ACsGT and 5P-ACsAG, respectively) are speci¢c
to the DNA containing methylcytosines. There can be no
doubt that the methyl group pointing into the major groove
serves to modulate the catalytic activity of the enzyme. Pre-
vious studies have demonstrated that with normal DNA the
camptothecin-induced cleavage occurs principally (but not ex-
clusively) at sites having a T and a G on the 5P and 3P sides of
the cleaved bond respectively [4,5]. Interestingly, the newly
created sites (arrows at the top of the gel in Fig. 4) all coincide
with a methylC-purine step which is analogous to a T-G step
as viewed from the major groove.
4. Conclusion
The major groove of double helical DNA containing 5-
methylcytosine residues is uniformly ¢lled with methyl groups
present on both cytosine and thymine residues. This steric
hindrance is not an obstacle for topoisomerase I binding
and cleavage. By contrast, the substitution of methylcytosine
for cytosines facilitates the binding reaction and reinforces the
stability of enzyme-DNA complexes. In addition, the
CCmethyl-C substitution changes the pattern of cleavage
sites detected in the presence of the speci¢c topoisomerase I
inhibitor camptothecin. New cleavage sites at a de¢ned MeC-
Pu dinucleotide sites are observed. From a major groove point
of view, the newly created sites at methyl-C-Pu steps resemble
the T-Pu steps encountered with normal DNA. There is there-
fore no doubt that the methyl group exposed in the major
groove of the double helix is a critical element for the inter-
action between topoisomerase I and DNA. This is consistent
with the view that DNA methylation of cytosine at CpG sites
in DNA can modulate the activity of topoisomerase I in mam-
malian cells [7]. It is well known that DNA methylation plays
a vital role in controlling gene expression and in maintaining
the integrity of the genome. These e¡ects may be mediated, at
least in part, by topoisomerase I.
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